BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17925398)

  • 1. The ATPase cycle of the endoplasmic chaperone Grp94.
    Frey S; Leskovar A; Reinstein J; Buchner J
    J Biol Chem; 2007 Dec; 282(49):35612-20. PubMed ID: 17925398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones.
    Dollins DE; Warren JJ; Immormino RM; Gewirth DT
    Mol Cell; 2007 Oct; 28(1):41-56. PubMed ID: 17936703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folding and Domain Interactions of Three Orthologs of Hsp90 Studied by Single-Molecule Force Spectroscopy.
    Jahn M; Tych K; Girstmair H; Steinmaßl M; Hugel T; Buchner J; Rief M
    Structure; 2018 Jan; 26(1):96-105.e4. PubMed ID: 29276035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grp94, the endoplasmic reticulum Hsp90, has a similar solution conformation to cytosolic Hsp90 in the absence of nucleotide.
    Krukenberg KA; Böttcher UM; Southworth DR; Agard DA
    Protein Sci; 2009 Sep; 18(9):1815-27. PubMed ID: 19554567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone.
    Immormino RM; Dollins DE; Shaffer PL; Soldano KL; Walker MA; Gewirth DT
    J Biol Chem; 2004 Oct; 279(44):46162-71. PubMed ID: 15292259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding.
    Rosser MF; Nicchitta CV
    J Biol Chem; 2000 Jul; 275(30):22798-805. PubMed ID: 10816561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine nucleotides and the regulation of GRP94-client protein interactions.
    Rosser MF; Trotta BM; Marshall MR; Berwin B; Nicchitta CV
    Biochemistry; 2004 Jul; 43(27):8835-45. PubMed ID: 15236592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the contribution of individual domains to the ATPase mechanism of Hsp90.
    Wegele H; Muschler P; Bunck M; Reinstein J; Buchner J
    J Biol Chem; 2003 Oct; 278(41):39303-10. PubMed ID: 12890674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle.
    Siligardi G; Hu B; Panaretou B; Piper PW; Pearl LH; Prodromou C
    J Biol Chem; 2004 Dec; 279(50):51989-98. PubMed ID: 15466438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity.
    Wassenberg JJ; Reed RC; Nicchitta CV
    J Biol Chem; 2000 Jul; 275(30):22806-14. PubMed ID: 10816560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interdomain communication suppressing high intrinsic ATPase activity of Sse1 is essential for its co-disaggregase activity with Ssa1.
    Kumar V; Peter JJ; Sagar A; Ray A; Jha MP; Rebeaud ME; Tiwari S; Goloubinoff P; Ashish F; Mapa K
    FEBS J; 2020 Feb; 287(4):671-694. PubMed ID: 31423733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change.
    Dollins DE; Immormino RM; Gewirth DT
    J Biol Chem; 2005 Aug; 280(34):30438-47. PubMed ID: 15951571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design.
    Immormino RM; Metzger LE; Reardon PN; Dollins DE; Blagg BS; Gewirth DT
    J Mol Biol; 2009 May; 388(5):1033-42. PubMed ID: 19361515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94.
    Wearsch PA; Voglino L; Nicchitta CV
    Biochemistry; 1998 Apr; 37(16):5709-19. PubMed ID: 9548957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Functional Complementation between Grp94 and Hsp90.
    Maharaj KA; Que NL; Hong F; Huck JD; Gill SK; Wu S; Li Z; Gewirth DT
    PLoS One; 2016; 11(11):e0166271. PubMed ID: 27824935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.
    Soldano KL; Jivan A; Nicchitta CV; Gewirth DT
    J Biol Chem; 2003 Nov; 278(48):48330-8. PubMed ID: 12970348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel quaternary domain interactions in the Hsp90 chaperone, GRP94.
    Chu F; Maynard JC; Chiosis G; Nicchitta CV; Burlingame AL
    Protein Sci; 2006 Jun; 15(6):1260-9. PubMed ID: 16731965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The conserved NxNNWHW motif in Aha-type co-chaperones modulates the kinetics of Hsp90 ATPase stimulation.
    Mercier R; Wolmarans A; Schubert J; Neuweiler H; Johnson JL; LaPointe P
    Nat Commun; 2019 Mar; 10(1):1273. PubMed ID: 30894538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal regions of Hsp90 are important for trapping the nucleotide during the ATPase cycle.
    Weikl T; Muschler P; Richter K; Veit T; Reinstein J; Buchner J
    J Mol Biol; 2000 Nov; 303(4):583-92. PubMed ID: 11054293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Grp on the Hsp90 mechanism.
    Richter K; Reinstein J; Buchner J
    Mol Cell; 2007 Oct; 28(2):177-9. PubMed ID: 17964255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.